ZIM Laboratories and Neuraxpharm granted marketing authorization for Buprenorphine Sublingual Film in Europe
According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD 355 million annually
According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD 355 million annually
Brings together industry experts to discuss preventive steps to protect pigs from African swine fever and best practises for pig farm management
Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
Exploring new opportunities within the fast-growing market of microfluidics
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS
Subscribe To Our Newsletter & Stay Updated